Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)

Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)

Introduction. In cirrhotic patients, hyperammonemia develops due to impaired ammonia detoxification and portosystemic blood shunting and is most commonly associated with hepatic encephalopathy and sarcopenia. Currently, there are questions regarding the diagnosis of hyperammonemia and the effect of...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Yu. Nadinskaia, M. V. Maevskaya, I. G. Bakulin, E. N. Bessonova, A. O. Bueverov, M. S. Zharkova, S. V. Okovityi, A. S. Ostrovskaya, K. A. Gulyaeva, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2024-03-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	pico ammonia measurement methods hyperammonemia hepatic encephalopathy sarcopenia hyperammonemia treatment lactulose rifaximin l-ornithine-l-aspartate lola branched-chain amino acids bcaa
Online Access:	https://www.gastro-j.ru/jour/article/view/945
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Valproate Metabolites and Hyperammonemia
by: J Gordon Millichap
Published: (1992-07-01)

Acute hyperammonemic encephalopathy masquerading as postoperative delirium in a patient who underwent lung surgery: a case report
by: Chao-Qin Chen, et al.
Published: (2025-07-01)

Efficacy and safety of L-ornithine L-aspartate combined with lactulose in treatment of hepatic encephalopathy: a systematic review and meta-analysis of randomized controlled trial
by: Hui Zhang, et al.
Published: (2025-04-01)

Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01)

An acute life-threatening episode of rhabdomyolysis, renal failure, altered mental status and hyperammonemia in an adult with 3-methylcrotonyl-CoA carboxylase deficiency
by: Rachel McGowan, et al.
Published: (2024-12-01)

Optimization of Treatment of Patients with Chronic Cardiac Insufficiency of the Ischemic Genesis and Hobnail Liver
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Hyperammonemia heightens anesthetic sensitivity in male rats with acute hepatic encephalopathy via affecting brain areas represented by the cerebellum
by: Sa Wang, et al.
Published: (2025-07-01)

Subdural Abscess From Acute Sinusitis in a Patient With Ornithine Transcarbamylase Deficiency
by: Yuya Ito, et al.
Published: (2025-02-01)

Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series
by: Miral M. Abdulghfar, et al.
Published: (2025-07-01)

Results of using L-ornitin-L-aspartate in the treatment of hepatic encephalopathy in liver transplantation
by: S. E. Voskanyan, et al.
Published: (2021-09-01)

A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab
by: Mauro Passucci, et al.
Published: (2023-01-01)

A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system
by: Stuti Bakshi, et al.
Published: (2025-07-01)

FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome: A rare cause of hyperammonemia
by: Ayça Burcu Kahraman, et al.
Published: (2025-06-01)

Hiperamonemia secundária ao uso terapêutico de ácido valpróico: relato de caso Hyperammonemia secondary to the use of valproic acid: case report
by: Marlene de Fátima Turcato, et al.
Published: (2005-06-01)

Liver resection for a congenital intrahepatic portosystemic shunt in a child with hyperammonemia and hypermanganesemia: a case report
by: Yuichi Takama, et al.
Published: (2020-04-01)

The problem of hyperammoniemia after orthotopic liver transplantation
by: S. V. Zhuravel, et al.
Published: (2025-06-01)

Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
by: E. M. Petrova, et al.
Published: (2021-06-01)

HMG‐CoA Synthase‐2 Deficiency: Neonatal Hyperammonemic Coma and Abnormal Metabolic Screening Resembling Maple Syrup Urine Disease
by: Hathaipat Vaseenon, et al.
Published: (2025-07-01)

Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety—a case report
by: Wei Chen, et al.
Published: (2025-07-01)

First manifestation of citrullinemia type I as Sandifer syndrome
by: Mustafa Kılıç, et al.
Published: (2017-12-01)

Prior immunity to Ureaplasma urealyticum protects against respiratory infection in immunosuppressed mice
by: Maha Y. Al-Jabri, et al.
Published: (2025-01-01)

Case Report: Management of intracranial hypertension in acute-on-chronic liver failure: a case of fulminant cerebral edema and acute-onset severe hyperammonemia in a patient with cirrhosis
by: Wei Tang, et al.
Published: (2025-03-01)

The impact of continuous renal replacement therapy for metabolic disorders in infants
by: Fatih Aygun, et al.
Published: (2018-02-01)

HYPERAMMONIUM IN PATIENTS WITH PRECIRRHOSIS STAGE: CLINICAL REALITY?
by: L. Yu. Ilchenko, et al.
Published: (2018-06-01)

ENCEPHALOPATHY AND HYPERLACTATEMIA AS A COMPLICATION OF 5-FLUOROURACIL TREATMENT
by: I. A. Kurmukov, et al.
Published: (2019-11-01)

EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
by: L. Yu. Ilchenko, et al.
Published: (2016-10-01)

An Alternative Mechanism of Glutamate Dehydrogenase Inhibition by EGCG: Promotion of Protein Degradation
by: Ziying Zeng, et al.
Published: (2025-06-01)

Mitochondrial Fatty Acid Beta-Oxidation Disorders in Children: Literature Review
by: Natalia V. Zhurkova, et al.
Published: (2023-01-01)

A transient blood IL-17 increase triggers neuroinflammation in cerebellum and motor incoordination in hyperammonemic rats
by: Yaiza M. Arenas, et al.
Published: (2024-11-01)

Clinical characteristics and long-term outcomes of 101 patients with urea cycle disorders in China
by: Ziyan Cen, et al.
Published: (2025-08-01)

Metabolic Disorders in Delirious Syndrome in Patients with Acute Poisoning with Gamma-Hydroxybutyric Acid and its Precursor
by: A. G. Sinenchenko, et al.
Published: (2020-10-01)

Carbamoyl phosphate synthetase 1 deficiency manifested in an adult treated with prednisone for polymyositis, and cured by live-donor liver transplantation
by: Kazuhiro Yokota, et al.
Published: (2025-06-01)

Minimal hepatic encephalopathy: a hidden threat to quality of life in cirrhosis patients
by: Mahtab Ghaemi
Published: (2025-07-01)

Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control
by: Taryn Diep, et al.
Published: (2025-03-01)

L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A
by: Nourhane Obeid, et al.
Published: (2023-03-01)

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
by: Yoshihiro Nagao, et al.
Published: (2022-10-01)

Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease
by: E. A. Kashukh, et al.
Published: (2019-09-01)

Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
by: M. V. Maevskaya, et al.
Published: (2024-08-01)

Comparative chemoreactomic analysis of ornithine aspartate, S-ademethionine and ursodeoxycholic acid
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

Safety assessment of L-ornithine oral intake in healthy subjects: a systematic review
by: Hyemin Yang, et al.
Published: (2025-05-01)